VIPR1 and cancer: In several cancer types, an upregulation of nuclear GPCRs has been observed as shown for the nuclear vasoactive intestinal peptide type 1 (VPAC1) receptor (gliomas [82]; breast cancer [77]) and for the nuclear C-X-C chemokine type 4 (CXCR4) receptor (non-small-cell lung cancer [66]).